Ligand validation:6O1A

FUL: beta-L-fucopyranose

FUL is a Ligand Of Interest in 6O1A designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6O1A_FUL_B_401	34%	29%	0.27	0.955	1.5	1.34	2	2	0	0	100%	1
6O1A_FUL_D_401	31%	32%	0.263	0.933	1.3	1.38	1	2	0	0	100%	1
6O1A_FUL_A_401	28%	44%	0.248	0.902	1.31	0.86	1	1	0	0	100%	1
6O1A_FUL_C_401	25%	51%	0.32	0.959	1.21	0.7	1	-	0	0	100%	1
6O1J_FUL_H_401	65%	45%	0.124	0.926	1.25	0.87	1	-	0	0	100%	1
1OFZ_FUL_A_1314	99%	48%	0.055	0.987	0.6	1.39	-	1	0	0	100%	0.65
6TR4_FUL_A_601	99%	66%	0.055	0.986	0.69	0.62	-	-	0	0	100%	0.5
5AJC_FUL_C_112	98%	61%	0.055	0.974	0.66	0.84	-	1	0	0	100%	0.3
4Z4T_FUL_A_604	97%	50%	0.062	0.98	0.95	0.99	-	-	0	0	100%	1
7C38_FUL_A_403	97%	56%	0.073	0.989	1.22	0.48	1	-	0	0	100%	0.6

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.